Fundacio Assistencial De Mutua De Terrassa Fpc

At Fundacio Assistencial De Mutua De Terrassa Fpc, clinical research in nervous system diseases focuses strongly on Alzheimer’s disease, with studies in early, mild, and dementia stages. These trials are designed to test new treatment options, explore symptom control, and better understand how the disease progresses over time.

• Early Alzheimer’s disease with biomarkers of inflammation
• Mild Alzheimer’s disease
• Treatment of Alzheimer’s disease dementia
• Evaluating novel therapies aimed at slowing cognitive decline

The site’s Neurology department also contributes to broader efforts in improving diagnosis and treatment response for patients living with progressive brain disorders.

Research in cardiovascular diseases includes trials for acute ischemic stroke, high-risk transient ischemic attack, and atrial fibrillation. These studies aim to reduce the risk of future stroke and improve prevention strategies for patients who may not be able to use standard anticoagulation treatments.

• Preventing recurrent ischemic stroke after a recent event
• Lowering stroke risk in atrial fibrillation
• Testing safer approaches for patients unsuitable for oral anticoagulation

This area reflects a clear focus on improving long-term protection against serious thromboembolic complications.

The site is active in hemic and lymphatic diseases, with studies involving acute myeloid leukemia, myelodysplastic syndrome, follicular lymphoma, marginal zone lymphoma, and Waldenström’s macroglobulinemia. The research is centered on testing new cancer treatments and comparing their effectiveness in difficult-to-treat blood cancers.

• New treatment approaches for AML and IDH1-mutated AML
• Therapy comparisons in relapsed or refractory lymphoma
• Options for relapsed/refractory Waldenström’s macroglobulinemia
• Evaluating treatment safety and disease control in hematologic malignancies

These studies support progress in oncology by seeking better outcomes for patients with relapsed, resistant, or newly diagnosed blood cancers.

Within neoplasms, the trials at this site include early-stage breast cancer and advanced ovarian, tubal, or peritoneal cancer. The research aims to understand long-term outcomes after treatment and to evaluate strategies that may improve disease control and survival in women’s cancers.

• Long-term follow-up in early invasive breast cancer
• Treatment strategies for advanced ovarian and related gynecologic cancers
• Assessing relapse patterns and progression-free survival

These studies combine follow-up research with treatment evaluation to help refine care pathways in oncology.

The site also participates in studies on bacterial infections and mycoses, especially severe community-acquired bacterial pneumonia. This research is focused on improving recovery, testing adjunctive treatment options, and strengthening care for patients with serious respiratory infection.

• Severe community-acquired bacterial pneumonia
• Evaluating new supportive treatment approaches
• Measuring clinical recovery and safety outcomes

These trials contribute to better management of complex infections in a hospital setting.